| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. | Nat Med | 2006 | 1.17 |
| 2 | Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors. | Exp Hematol Oncol | 2013 | 0.98 |